Cargando…
Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
Bcl-2 has been demonstrated to inhibit apoptosis in breast cancer cells in vitro, and the ratio between Bcl-2 and its proapoptotic homologue Bax seems to be an important determinant of cellular sensitivity to induction of apoptosis. However, little information is available on the relationship betwee...
Autores principales: | van Slooten, H. J., van de Vijver, M. J., van de Velde, C. J., van Dierendonck, J. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149956/ https://www.ncbi.nlm.nih.gov/pubmed/9514059 |
Ejemplares similares
-
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
por: van Slooten, H. J., et al.
Publicado: (1996) -
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
por: Tollenaar, R. A., et al.
Publicado: (1998) -
Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.
por: van Slooten, H. J., et al.
Publicado: (1995) -
Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.
por: Marinelli, A., et al.
Publicado: (1991) -
Prognostic value of bcl-2 expression in invasive breast cancer.
por: Hellemans, P., et al.
Publicado: (1995)